PaxMedica Inc. [NASDAQ: PXMD] gained 18.43% on the last trading session, reaching $2.57 price per share at the time. The company report on August 26, 2022 that Craft Capital Management Announces Pricing of Initial Public Offering for PaxMedica, Inc.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Shares will Trade on Nasdaq Capital Market under Ticker Symbol “PXMD”.
PaxMedica, Inc. (Nasdaq:PXMD), a clinical stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms, today announced the pricing of its initial public offering of 1,545,454 shares of its common stock at a public price of $5.25 per share. The gross proceeds to PaxMedica from the offering, before deducting underwriting discounts, commissions and offering expenses, are expected to be approximately $8.1 million. All of the shares are being offered by PaxMedica. In addition, PaxMedica has granted the underwriters a 45-day option to purchase an additional 231,818 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.
PaxMedica Inc. represents 10.02 million in outstanding shares, while the company has a total market value of $25.52 million with the latest information. PXMD stock price has been found in the range of $2.15 to $3.4499.
If compared to the average trading volume of 7.35M shares, PXMD reached a trading volume of 11766732 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Trading performance analysis for PXMD stock
PaxMedica Inc. [PXMD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -16.01.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The RSI for the last a single of trading hit 37.35, and the three-weeks RSI is set at 38.57 for PaxMedica Inc. [PXMD]. The present Moving Average recorded at 2.45 for the last single week of trading.